A-Alpha Bio Inc

Home

A-Alpha Bio Inc
Profile last edited on: 12/18/2020

   Cell-based tools for quantitative and high-throughput measurements of protein interactions
Year Founded
First SBIR Year
Latest SBIR Award
Program Status
Active

WikiProfile

Contact Information

4000 Mason Road
Seattle, WA 98195
  (206) 890-9704
  contact@aalphabio.com
  www.aalphabio.com

Public Profile

Organized around the objective of accelerating target discovery, library screening, and preclinical drug characterization by providing cell-based tools for quantitative and high-throughput measurements of protein interactions, A-Alpha Bio has developed a synthetic biology platform to aid in the development of drugs that interact with multiple targets. The firm's proprietary synthetic biology platform, - designated AlphaSeq - enables screening against thousands of targets in a single experimental step. An all-at-once approach saves time, reduces cost, and improves success rates. The effort is to accelerate target discovery, library screening, and preclinical drug characterization by providing cell-based tools for quantitative and high-throughput measurements of protein interactions.
 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :